Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Quantitative assessment of insertion sequence impact on bacterial genome architecture.

Adams MD, Bishop B, Wright MS.

Microb Genom. 2016 Jul 18;2(7):e000062. doi: 10.1099/mgen.0.000062. eCollection 2016 Jul.

2.

Bibliometric analysis of global scientific research on carbapenem resistance (1986-2015).

Sweileh WM, Shraim NY, Al-Jabi SW, Sawalha AF, AbuTaha AS, Zyoud SH.

Ann Clin Microbiol Antimicrob. 2016 Sep 23;15(1):56.

3.

Biofilm may not be Necessary for the Epidemic Spread of Acinetobacter baumannii.

Hu Y, He L, Tao X, Meng F, Zhang J.

Sci Rep. 2016 Aug 25;6:32066. doi: 10.1038/srep32066.

4.

Head-to-Head Comparison of Two Multi-Locus Sequence Typing (MLST) Schemes for Characterization of Acinetobacter baumannii Outbreak and Sporadic Isolates.

Tomaschek F, Higgins PG, Stefanik D, Wisplinghoff H, Seifert H.

PLoS One. 2016 Apr 12;11(4):e0153014. doi: 10.1371/journal.pone.0153014. eCollection 2016.

5.

Resistance and integron characterization of Acinetobacter baumannii in a teaching hospital in Chongqing, China.

Huang C, Long Q, Qian K, Fu T, Zhang Z, Liao P, Xie J.

New Microbes New Infect. 2015 Oct 3;8:103-8. doi: 10.1016/j.nmni.2015.09.015. eCollection 2015 Nov.

6.

The Prevalence of IS Aba 1 and IS Aba 4 in Acinetobacter baumannii Species of Different International Clone Lineages Among Patients With Burning in Tehran, Iran.

Bahador A, Raoo An R, Farshadzadeh Z, Beitollahi L, Khaledi A, Rahimi S, Mokhtaran M, Mehrabi Tavana A, Esmaeili D.

Jundishapur J Microbiol. 2015 Jul 27;8(7):e17167. doi: 10.5812/jjm.17167v2. eCollection 2015 Jul.

7.

Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study.

Wu W, He Y, Lu J, Lu Y, Wu J, Liu Y.

PLoS One. 2015 Sep 4;10(9):e0137174. doi: 10.1371/journal.pone.0137174. eCollection 2015.

8.

Diversity of multi-drug resistant Acinetobacter baumannii population in a major hospital in Kuwait.

Vali L, Dashti K, Opazo-Capurro AF, Dashti AA, Al Obaid K, Evans BA.

Front Microbiol. 2015 Jul 23;6:743. doi: 10.3389/fmicb.2015.00743. eCollection 2015.

9.

Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France.

Jeannot K, Diancourt L, Vaux S, Thouverez M, Ribeiro A, Coignard B, Courvalin P, Brisse S.

PLoS One. 2014 Dec 17;9(12):e115452. doi: 10.1371/journal.pone.0115452. eCollection 2014.

10.

Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: results of the first cross-sectional countrywide survey.

Principe L, Piazza A, Giani T, Bracco S, Caltagirone MS, Arena F, Nucleo E, Tammaro F, Rossolini GM, Pagani L, Luzzaro F; AMCLI-CRAb Survey Participants..

J Clin Microbiol. 2014 Aug;52(8):3004-10. doi: 10.1128/JCM.00291-14. Epub 2014 Jun 11.

11.

Emergence of Acinetobacter baumannii international clone II in Brazil: reflection of a global expansion.

Martins N, Dalla-Costa L, Uehara AA, Riley LW, Moreira BM.

Infect Genet Evol. 2013 Dec;20:378-80. doi: 10.1016/j.meegid.2013.09.028. Epub 2013 Oct 10.

12.

Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.

Rumbo C, Gato E, López M, Ruiz de Alegría C, Fernández-Cuenca F, Martínez-Martínez L, Vila J, Pachón J, Cisneros JM, Rodríguez-Baño J, Pascual A, Bou G, Tomás M; Spanish Group of Nosocomial Infections and Mechanisms of Action and Resistance to Antimicrobials (GEIH-GEMARA).; Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).; Spanish Network for Research in Infectious Diseases(REIPI)..

Antimicrob Agents Chemother. 2013 Nov;57(11):5247-57. doi: 10.1128/AAC.00730-13. Epub 2013 Aug 12.

13.

Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms.

Di Bonito M, Caiazzo S, Iannazzone M, Miccichè V, De Marco G, De Robertis E, Tufano R, Piazza O.

Transl Med UniSa. 2012 Apr 30;3:15-21. Print 2012 May.

14.

Acinetobacter baumannii producing OXA-23 detected in the Czech Republic.

Senkyrikova M, Husickova V, Chroma M, Sauer P, Bardon J, Kolar M.

Springerplus. 2013 Jul 2;2(1):296. doi: 10.1186/2193-1801-2-296. Print 2013 Dec.

15.

Acinetobacter phage genome is similar to Sphinx 2.36, the circular DNA copurified with TSE infected particles.

Longkumer T, Kamireddy S, Muthyala VR, Akbarpasha S, Pitchika GK, Kodetham G, Ayaluru M, Siddavattam D.

Sci Rep. 2013;3:2240. doi: 10.1038/srep02240.

16.

Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil.

Coelho-Souza T, Reis JN, Martins N, Martins IS, Menezes AO, Reis MG, Silva NO, Dias RC, Riley LW, Moreira BM.

Clin Microbiol Infect. 2013 May;19(5):E241-4. doi: 10.1111/1469-0691.12145. Epub 2013 Feb 11.

17.

Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis typing of Acinetobacter baumannii in China.

Hu Y, Li B, Jin D, Cui Z, Tao X, Zhang B, Zhang J.

J Clin Microbiol. 2013 Apr;51(4):1263-8. doi: 10.1128/JCM.03108-12. Epub 2013 Jan 23.

18.

First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain.

Espinal P, Macià MD, Roca I, Gato E, Ruíz E, Fernández-Cuenca F, Oliver A, Rodríguez-Baño J, Bou G, Tomás M, Vila J.

Antimicrob Agents Chemother. 2013 Jan;57(1):589-91. doi: 10.1128/AAC.01157-12. Epub 2012 Oct 15.

19.

Molecular analysis of Acinetobacter baumannii isolates from invasive infections in 2009 in Poland.

Izdebski R, Fiett J, Hryniewicz W, Gniadkowski M.

J Clin Microbiol. 2012 Nov;50(11):3813-5. doi: 10.1128/JCM.02271-12. Epub 2012 Sep 12. No abstract available.

20.

Studies on New Delhi Metallo-Beta-Lactamse-1 producing Acinetobacter baumannii isolated from donor swab in a tertiary eye care centre, India and structural analysis of its antibiotic binding interactions.

Sowmiya M, Umashankar V, Muthukumaran S, Madhavan HN, Malathi J.

Bioinformation. 2012;8(10):445-52. doi: 10.6026/97320630008445. Epub 2012 May 31.

Supplemental Content

Support Center